Patent 7910701 was granted and assigned to ZymoGenetics on March, 2011 by the United States Patent and Trademark Office.
Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.”